| Edit |   |
|---|
| Product Name | OGT 2115 |
|---|
| Description | Heparanase inhibitor (IC50 = 0.4 μM) that displays no major inhibition of human cytochrome P450 isoenzymes (IC50 > 30 μM). Exhibits antiangiogenic properties in vitro (IC50 = 1 μM). Purity 97%. MW (observed): 495.3 |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid |
|---|
| Gene, Accession, CAS # | CAS: 853929-59-6 |
|---|
| Catalog # | 2710/1 |
|---|
| Price | |
|---|
| Order / More Info | OGT 2115 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 29121099, 29581478 |
|---|